Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: BBB

May 18, 2026 CD as API / Pharma applications

HPBCD against acute and subacute infarcts in a mouse model of ischemic stroke

HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously

Continue reading

March 18, 2026 CD as API / CD derivatives / Pharma applications

HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke

Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona

Continue reading

December 19, 2025 CD derivatives / Pharma applications

Cyclodextrin-based carriers for targeted drug delivery, a new review

This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,

Continue reading

October 20, 2025 CD as API / Pharma applications

Cholesterol in the CNS: functions, recycling and remyelination

The central nervous system ( CNS) is increasingly recognized as a cholesterol-rich organ. While the brain accounts for approximately 5%

Continue reading

April 2, 2025 Drug delivery / Food / Pharma applications

The Current Status, Hotspots, and Development Trends of Nanoemulsions: A Comprehensive Bibliometric Review

Nanoemulsions, which are characterized by their nanometer-scale droplets, have gained significant attention in different fields, such as medicine, food, cosmetics,

Continue reading

March 26, 2024 Drug delivery / Pharma applications

Recent Advances in Intranasal Administration for Brain-Targeting Delivery

Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain

Continue reading

August 30, 2023 CD derivatives / Drug delivery / Pharma applications

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin

Huntington’s disease (HD) is a progressive inherited neurodegenerative disease caused by a CAG repeat expansion in the huntingtin gene, which

Continue reading

July 21, 2023 CD as API / Pharma applications

Remembering Dr. David Begley

With immense sadness we have to announce that an outstanding Scientist, Dr. David Begley passed away on Thursday 6th July

Continue reading

September 13, 2021 CD as API / Pharma applications

Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases

The complexity and organization of the central nervous system (CNS) is widely modulated by the presence of the blood–brain barrier

Continue reading

July 9, 2021 Drug delivery / Events / Pharma applications

Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2021),

“4th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” (PDDS 2021) is going to be held during September

Continue reading

Posts pagination

1 2 Next Posts»

Recent Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • New Hungarian Medicine on the Horizon?

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (175)

Top Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • New Hungarian Medicine on the Horizon?
  • Chapter 3: Professor Casu and Cyclodextrins
  • Novel medicament comprising fosaprepitant/SBECD has been approved.
  • Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
  • New book on beta-cyclodextrin and its derivatives
  • A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
  • Wound dressing based on PVP/PVA nanofibers containing β-cyclodextrin/curcumin complex
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Book chapter: Functionalized cyclodextrins in drug delivery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...